Ulrika Segersten

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Correction: Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations.

Correction: Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations.

Journal: PloS one
Published: May 31, 2024

Comprehensive genomic characterization of early-stage bladder cancer.

Comprehensive genomic characterization of early-stage bladder cancer.

Journal: Nature genetics
Published: October 31, 2023

Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer.

Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer.

Journal: BMC cancer
Published: November 14, 2022

An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers.

An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers.

Journal: EBioMedicine
Published: August 29, 2022

PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity.

PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity.

Journal: Scientific reports
Published: April 11, 2022

Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations.

Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations.

Journal: PloS one
Published: December 15, 2020

Combination of biomarkers for neoadjuvant systemic chemotherapy before cystectomy in patients with urinary bladder cancer.

Combination of biomarkers for neoadjuvant systemic chemotherapy before cystectomy in patients with urinary bladder cancer.

Journal: Translational research : the journal of laboratory and clinical medicine
Published: October 21, 2020

The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types.

The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types.

Journal: EBioMedicine
Published: October 13, 2020

Proteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer.

Proteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer.

Journal: Scientific reports
Published: July 10, 2020

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.

Journal: Nature communications
Published: June 11, 2020

Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome.

Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome.

Journal: Scientific reports
Published: July 12, 2019

Is Bcl-2 a predictive marker of neoadjuvant chemotherapy response in patients with urothelial bladder cancer undergoing radical cystectomy?

Is Bcl-2 a predictive marker of neoadjuvant chemotherapy response in patients with urothelial bladder cancer undergoing radical cystectomy?

Journal: Scandinavian journal of urology
Published: February 27, 2019
Showing 1-12 of 30

Last Updated: 09/26/2026